- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
research use only
Cat.No.S8654
| Related Targets | PI3K Akt mTOR GSK-3 ATM/ATR DNA-PK PDPK1 PTEN PP2A PDK |
|---|---|
| Other AMPK Products | Dorsomorphin Dihydrochloride Dorsomorphin AICAR (Acadesine) A-769662 GSK621 WZ4003 Phenformin HCl HTH-01-015 BAY-3827 O-304 |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| Sf21 | Function assay | 30 mins | Agonist activity at human recombinant phosphorylated AMPK complex 7 alpha2/beta1/gamma1 expressed in baculovirus infected Sf21 cells assessed as phosphorylation of 5-FAM-labeled SAMS substrate preincubated for 30 mins in presence of AMPK activator followe, EC50=0.002μM | 29035567 | ||
| Sf21 | Function assay | 30 mins | Activation of full length human recombinant AMPK alpha1/beta1/gamma1 expressed in baculovirus infected sf21 cells using SAMS peptide substrate after 30 mins in presence of [33P]ATP by TopCount analysis, EC50=0.003μM | 27727125 | ||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 12 mg/mL
(27.78 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 431.87 | Formula | C24H18ClN3O3 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 1219739-36-2 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC1=C(C=C(C=C1)OC2=NC3=C(N2)C=C(C(=C3)C4=CC5=C(C=C4)N(C=C5)C)Cl)C(=O)O | ||
| Targets/IC50/Ki |
AMPK
|
|---|---|
| In vitro |
EX229 (compound 991) activates AMPK in incubated rat epitrochlearis skeletal muscle and increases glucose uptake upon incubation with rat skeletal muscle. The stimulation of skeletal muscle glucose uptake by this compound is PI3K/PKB-independent, while AMPK-dependent. It also increases fatty acid oxidation and glucose uptake in L6 myotubes. |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.